Alimera Sciences Reports Third Quarter 2013 Financial Results
Published: Nov 12, 2013
ATLANTA, Nov. 11, 2013 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.